Patents
Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
02/2001
02/27/2001US6194393 A glycoside containing an anomeric sulfoxide and nucleophilic functional groups and having potential glycosyl accepting/donating characteristics and an activating agent; rapid construction oligosaccharides; glycosylation; library
02/27/2001US6194387 6-O-aklyl erythromycin B oxime
02/27/2001CA2316647A1 Treatment or prevention of coccidiosis
02/27/2001CA2102454C Erythromycin derivatives, process for the preparation thereof, and use thereof as medicaments
02/22/2001WO2001011963A1 Oral treatment of companion animals with ectoparasiticidal spinosyns
02/22/2001WO2000078773A3 Process for preparing 6-o-alkenyl-substituted erythromycin deriv atives
02/22/2001WO1999050275A3 Macrolide lhrh antagonists
02/21/2001CN1284961A Erythromycin derivatives
02/21/2001CN1284492A Method of producing mixture of apium essence and apiin
02/20/2001US6191271 Synthetic divalent sLex containing polylactosamines and methods for use
02/20/2001US6191118 Antibiotics
02/15/2001WO2001010881A1 Fluorogenic compounds and uses therefor
02/15/2001WO2001010880A1 Erythromycin a derivatives
02/15/2001WO2001010879A1 Erythromycin a derivatives
02/15/2001WO2001010878A1 Erythromycin a derivatives
02/15/2001WO2000062783A3 Ketolide antibacterials
02/14/2001EP0815120B1 17-difluoromethylene-oestratrienes
02/14/2001CN1284081A Novel macrolides compounds
02/13/2001CA2044317C Hair restorer
02/07/2001EP1073648A1 12,13-Modified epothilone derivatives
02/07/2001EP1073647A1 12,13-cyclopropane epothilone derivatives
02/07/2001CN1283234A Method for suppressing multiple drug resistant in cancer cells
02/07/2001CN1283199A Z-halo-6-o-substituted ketolide derivatives
02/07/2001CN1282584A Application of icariin in preventing and treating sexual disfunction and improving diseases associated with vasoconstriction
02/01/2001WO2000058326A3 Novel method for the production of etoposide
01/2001
01/31/2001EP1071692A1 Method for laminaribiose synthesis
01/31/2001CN1282251A Method and material for treating and preventing mucosal tissue inflammation
01/30/2001US6180662 Mixture of cinnamic acid, antioxidant, enzyme, microbiocides and viricides
01/30/2001US6180661 Water dispersible concentrate
01/24/2001EP1070077A1 15-membered lactams ketolides with antibacterial activity
01/24/2001CN1061047C Process of preparing etoposide phosphate
01/23/2001US6177409 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1H)ons derivatives from aminomonosaccharides or aminoitols, products obtained by this method and their applications
01/18/2001WO2001003681A2 Use of flavones, coumarins and related compounds to treat infections
01/18/2001WO2000063225A3 Macrolide antiinfective agents
01/18/2001WO2000063224A3 Macrolide antiinfective agents
01/18/2001WO1999064049A9 Novel antibacterial agents
01/18/2001CA2375647A1 Use of flavones, coumarins and related compounds to treat infections
01/17/2001EP1067969A1 Polyene macrolide derivatives, use for vectoring molecules
01/17/2001CN1280585A Novel 3.6-hemiketals from the class of 9a-azalides
01/17/2001CN1280499A Use of ginkgo biloba extracts for preparing a medicine
01/17/2001CN1280133A Producing technology for lowering lincomycin B content in lincomycin by vibrative sieve plate extraction tower
01/16/2001US6174864 Methods for the prevention or treatment of inflammatory bowel diseases
01/16/2001CA2100821C Stereocontrolled glycosidation
01/16/2001CA2062933C Novel process for the preparation of 9-deoxo-9(z)-hydroxyiminoerythromycin a
01/16/2001CA2022962C Process for the preparation of extracts having high content in anthocyanosides
01/11/2001WO2001002414A1 Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
01/11/2001WO2001002413A1 BAFIlOMYCIN DERIVATIVES WITH ANTICANCER ACTIVITY
01/11/2001WO2000053169A8 Method of inhibiting a chaperone protein
01/10/2001EP1066832A1 Preventives and remedies for ischemic reflow disorder
01/10/2001EP1066307A1 3',3'-n-bis-substituted macrolide lhrh antagonists
01/10/2001EP1066304A1 Macrolide lhrh antagonists
01/10/2001CN1060483C Intermediate of doramectin for antiparastic chemical and its preparing method
01/10/2001CN1060482C Novel polyhydro derivatives of tylosine and process for their preparation
01/09/2001US6172206 Stability
01/09/2001US6172205 Synthetic process toward total synthesis of eleutherobin and its analogues and uses thereof
01/04/2001WO2001000640A1 Macrolides
01/04/2001WO2001000582A1 Preparation of quinoline-substituted carbonate and carbamate derivatives
01/04/2001WO2000044761A3 Ketolide antibiotics
01/04/2001CA2850203A1 Preparation of quinoline-substituted carbonate and carbamate derivatives
01/04/2001CA2719425A1 Preparation of quinoline-substituted carbonate and carbamate derivatives
01/03/2001CN1278722A 8a-azalides as veterinary antimicrobial agents for animals
01/02/2001US6169168 Erythromycin A derivatives
12/2000
12/28/2000WO2000078773A2 Process for preparing 6-o-alkenyl-substituted erythromycin deriv atives
12/28/2000WO2000078772A2 Antibiotic agents
12/28/2000WO2000078764A1 Process for making morphine-6-glucuronide and its analogues using haloglucuronate ester intermediates
12/28/2000WO2000078323A1 A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases
12/28/2000CA2375358A1 Antibiotic agents
12/28/2000CA2375274A1 Process for making morphine-6-glucuronide and its analogues using haloglucuronate ester intermediates
12/27/2000EP1062361A2 Water-soluble coumarin fluorescent enzyme substrates
12/27/2000EP1062223A1 Composition containing a precursor capable of being hydrolysed by glucocerebrosidase
12/27/2000CN1278266A 6,11-bridged erythromycin derivatives
12/27/2000CN1278178A Use of macrolies for treating cancer and macular degeneration
12/26/2000US6165986 Erythromycin a derivatives
12/26/2000US6165985 Oxidative glycol cleavage of 2',3'-dihydroxypent-2-yl side chain of 2,4,6,8,10-pentamethyl-11-(2',3'-dihydroxypen-2'-yl)-12,13-dio xabiclylo(8,2,1)-trideca-8-ene-1-one into acetyl side chain
12/26/2000CA2183453C Antiparasitic agents
12/21/2000WO2000077182A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds
12/21/2000WO2000077017A1 Novel amorphous form of clarithromycin
12/21/2000WO2000077016A1 DERIVATIVES OF 4'-DEMYCAROSYL-8a-AZA-8a-HOMOTYLOSIN
12/21/2000CA2376446A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds
12/21/2000CA2375812A1 Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin
12/20/2000CN1059678C Subtance IT-62-B
12/19/2000US6162794 Erythromycin derivatives
12/19/2000US6162793 Bactericides and antibiotics
12/14/2000WO2000075156A1 6-o-carbamate ketolide derivatives
12/14/2000DE19926770A1 Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen A nucleic acid fragment and vector containing a halogenase, and a process for the halogenation of chemical compounds
12/13/2000EP1058687A1 Nucleosides
12/13/2000CN1059445C Erythromycin derivs, method for preparing same and use thereof as drugs
12/12/2000US6160102 Oligonucleotide-anthracycline and oligonucleotide-anthracyclinone conjugates
12/12/2000US6159945 9-amino-3-keto erythromycin derivatives
12/07/2000WO2000073317A1 3-modified leucomycin derivatives
12/06/2000CN1275983A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV)
12/06/2000CN1059212C 9-N-ethenyl derivatives of 9 (S)-erythromycylamine
11/2000
11/30/2000WO2000071557A1 13-methyl-erythromycin derivatives
11/29/2000EP1054891A1 Prodrugs
11/29/2000CN1275129A Oligosaccharide derivatives and process for producing the same
11/23/2000WO2000069875A1 C-2 modified erythromycin derivatives
11/23/2000WO2000069874A1 Novel crystalline forms of a macrolide antibiotic
11/23/2000WO2000040589A3 Novel derivatives from the class of oleandomycin
11/23/2000WO2000037608A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
11/23/2000WO2000034295A3 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 117